Skip to main content
Premium Trial:

Request an Annual Quote

CardioDx Raises $58M in Private Financing

NEW YORK (GenomeWeb News) – Cardiovascular genomics diagnostics company CardioDx today announced the completion of a $58 million equity financing round.

The company, which recently received Medicare coverage for its coronary artery disease test called Corus CAD, will use the funding to support commercialization of the gene expression test and to develop other genomics diagnostics for cardiovascular disease, it said.

David Levison, president and CEO of CardioDx, said in a statement that the cash injection positions the company to capitalize on the "significant" opportunity to improve the lives of patients with obstructive coronary artery disease, and the Medicare decision "further validates the clinical benefit of and economic rationale for Corus CAD. This additional capital will help us expand our sales force in the US, further broaden reimbursement coverage, and support continued investments in research and development of new products."

Corus CAD was launched in June 2009 as a laboratory-developed test.

Investors in the financing round include Singapore-based investment firm Temasek, as well as existing investors Longitude Capital; Artiman Ventures; Kleiner, Perkins, Caufield & Byers; JP Morgan; Mohr Davidow Ventures; TPG Biotech; Intel Capital; Acadia Woods Partners; Bright Capital; Pappas Ventures; DAG Ventures; Asset Management Group; and GE Capital.

All previous investors also participated in the round, CardioDx said.

In May 2011, the Palo Alto, Calif.-based company raised $60 million in private financing.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.